Tumor innervation: peripheral nerves take control of the tumor microenvironment

被引:125
作者
Gysler, Stefan M. [1 ,2 ]
Drapkin, Ronny [1 ,2 ,3 ]
机构
[1] Univ Penn, Perelman Sch Med, Div Gynecol Oncol, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Obstet & Gynecol, Penn Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Basser Ctr BRCA, Philadelphia, PA 19104 USA
关键词
PHASE-III TRIAL; POSITIVE SOLID TUMORS; PERINEURAL INVASION; INTERCELLULAR COMMUNICATION; EXTRACELLULAR VESICLES; NEUROPEPTIDE-Y; BETA-BLOCKERS; GROWTH-FACTOR; DOUBLE-BLIND; STEM-CELLS;
D O I
10.1172/JCI147276
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In recent decades, cancer research has expanded exponentially beyond the study of abnormally dividing cells to include complex and extensive heterotypic interactions between cancer and noncancer cells that constitute the tumor microenvironment (TME). Modulation of stromal, immune, and endothelial cells by cancer cells promotes proliferation, survival, and metabolic changes that support tumor growth and metastasis. Recent evidence demonstrates that tumors can recruit peripheral nerves to the TME, leading to enhanced tumor growth in a range of cancer models through distinct mechanisms. This process, termed tumor innervation, is associated with an aggressive tumor phenotype and correlates with poor prognosis in clinical studies. Therefore, the peripheral nervous system may play an underrecognized role in cancer development, harboring targetable pathways that warrant investigation. To date, nerves have been implicated in driving proliferation, invasion, metastasis, and immune evasion through locally delivered neurotransmitters. However, emerging evidence suggests that cell-cell communication via exosomes induces tumor innervation, and thus exosomes may also mediate neural regulation of the TME. In this Review, seminal studies establishing tumor innervation are discussed, and known and putative signaling mechanisms between peripheral nerves and components of the TME are explored as a means to identify potential opportunities for therapeutic intervention. In recent decades, cancer research has expanded exponentially beyond the study of abnormally dividing cells to include complex and extensive heterotypic interactions between cancer and noncancer cells that constitute the tumor microenvironment (TME). Modulation of stromal, immune, and endothelial cells by cancer cells promotes proliferation, survival, and metabolic changes that support tumor growth and metastasis. Recent evidence demonstrates that tumors can recruit peripheral nerves to the TME, leading to enhanced tumor growth in a range of cancer models through distinct mechanisms. This process, termed tumor innervation, is associated with an aggressive tumor phenotype and correlates with poor prognosis in clinical studies. Therefore, the peripheral nervous system may play an underrecognized role in cancer development, harboring targetable pathways that warrant investigation. To date, nerves have been implicated in driving proliferation, invasion, metastasis, and immune evasion through locally delivered neurotransmitters. However, emerging evidence suggests that cell-cell communication via exosomes induces tumor innervation, and thus exosomes may also mediate neural regulation of the TME. In this Review, seminal studies establishing tumor innervation are discussed, and known and putative signaling mechanisms between peripheral nerves and components of the TME are explored as a means to
引用
收藏
页数:11
相关论文
共 112 条
[31]   Neuronal Trans-Differentiation in Prostate Cancer Cells [J].
Farach, Andrew ;
Ding, Yi ;
Lee, MinJae ;
Creighton, Chad ;
Delk, Nikki A. ;
Ittmann, Michael ;
Miles, Brian ;
Rowley, David ;
Farach-Carson, Mary C. ;
Ayala, Gustavo E. .
PROSTATE, 2016, 76 (14) :1312-1325
[32]   Embryonic Cerebrospinal Fluid Nanovesicles Carry Evolutionarily Conserved Molecules and Promote Neural Stem Cell Amplification [J].
Feliciano, David M. ;
Zhang, Shiliang ;
Nasrallah, Carole M. ;
Lisgo, Steven N. ;
Bordey, Angelique .
PLOS ONE, 2014, 9 (02)
[33]   Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis [J].
Fu, Qiaofen ;
Chen, Nan ;
Ge, Chunlei ;
Li, Ruilei ;
Li, Zhen ;
Zeng, Baozhen ;
Li, Chunyan ;
Wang, Ying ;
Xue, Yuanbo ;
Song, Xin ;
Li, Heng ;
Li, Gaofeng .
ONCOIMMUNOLOGY, 2019, 8 (07)
[34]   Innate and adaptive immune cells in the tumor microenvironment [J].
Gajewski, Thomas F. ;
Schreiber, Hans ;
Fu, Yang-Xin .
NATURE IMMUNOLOGY, 2013, 14 (10) :1014-1022
[35]   Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer [J].
Garcia-Recio, Susana ;
Fuster, Gemma ;
Fernandez-Nogueira, Patricia ;
Pastor-Arroyo, Eva M. ;
Park, So Yeon ;
Mayordomo, Cristina ;
Ametller, Elisabet ;
Mancino, Mario ;
Gonzalez-Farre, Xavier ;
Russnes, Hege G. ;
Engel, Pablo ;
Costamagna, Domiziana ;
Fernandez, Pedro L. ;
Gascon, Pedro ;
Almendro, Vanessa .
CANCER RESEARCH, 2013, 73 (21) :6424-6434
[36]   Exosomes mediate cell contact-independent ephrin-Eph signaling during axon guidance [J].
Gong, Jingyi ;
Koerner, Roman ;
Gaitanos, Louise ;
Klein, Ruediger .
JOURNAL OF CELL BIOLOGY, 2016, 214 (01) :35-44
[37]   Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer [J].
Govindan, Ramaswamy ;
Szczesna, Aleksandra ;
Ahn, Myung-Ju ;
Schneider, Claus-Peter ;
Gonzalez Mella, Pablo Fernando ;
Barlesi, Fabrice ;
Han, Baohui ;
Ganea, Doina Elena ;
Von Pawel, Joachim ;
Vladimirov, Vladimir ;
Fadeeva, Natalia ;
Lee, Ki Hyeong ;
Kurata, Takayasu ;
Zhang, Li ;
Tamura, Tomohide ;
Postmus, Pieter E. ;
Jassem, Jacek ;
O'Byrne, Kenneth ;
Kopit, Justin ;
Li, Mingshun ;
Tschaika, Marina ;
Reck, Martin .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (30) :3449-+
[38]   Exosomes and their roles in immune regulation and cancer [J].
Greening, David W. ;
Gopal, Shashi K. ;
Xu, Rong ;
Simpson, Richard J. ;
Chen, Weisan .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2015, 40 :72-81
[39]   Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy [J].
Grytli, Helene Hartvedt ;
Fagerland, Morten Wang ;
Fossa, Sophie D. ;
Tasken, Kristin Austlid ;
Haheim, Lise Lund .
PROSTATE, 2013, 73 (03) :250-260
[40]   Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1 D-Trp5,7,9,Leu11]SP:: A dual inhibitor of growth and angiogenesis in pancreatic cancer [J].
Guha, S ;
Eibl, G ;
Kisfalvi, K ;
Fan, RS ;
Burdick, M ;
Reber, H ;
Hines, OJ ;
Strieter, R ;
Rozengurt, E .
CANCER RESEARCH, 2005, 65 (07) :2738-2745